AAAAAA

   
Results: << | 901-925 | 926-950 | 951-975 | 976-1000 | >>

Table of contents of journal: *Hepatology

Results: 951-975/15678
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
Authors: Krowka, MJ Frantz, RP McGoon, MD Severson, C Plevak, DJ Wiesner, RH
Citation: Mj. Krowka et al., Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension, HEPATOLOGY, 30(3), 1999, pp. 641-648
Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation
Authors: Merli, M Leonetti, F Riggio, O Valeriano, V Ribaudo, MC Sprati, F Tisone, G Casciani, CU Capocaccia, L
Citation: M. Merli et al., Glucose intolerance and insulin resistance in cirrhosis are normalized after liver transplantation, HEPATOLOGY, 30(3), 1999, pp. 649-654
Resting energy expenditure should be measured in patients with cirrhosis, not predicted
Authors: Madden, AM Morgan, MY
Citation: Am. Madden et My. Morgan, Resting energy expenditure should be measured in patients with cirrhosis, not predicted, HEPATOLOGY, 30(3), 1999, pp. 655-664
Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors
Authors: Alanen, KW Chakrabarti, S Rawlins, JJ Howson, W Jeffrey, G Adams, PC
Citation: Kw. Alanen et al., Prevalence of the C282Y mutation of the hemochromatosis gene in liver transplant recipients and donors, HEPATOLOGY, 30(3), 1999, pp. 665-669
Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients
Authors: Jimenez, W Ros, J Morales-Ruiz, M Navasa, M Sole, M Colmenero, J Sort, P Rivera, F Arroyo, V Rodes, J
Citation: W. Jimenez et al., Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients, HEPATOLOGY, 30(3), 1999, pp. 670-676
Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas
Authors: Bonura, C Paterlini-Brechot, P Brechot, C
Citation: C. Bonura et al., Structure and expression of Tg737, a putative tumor suppressor gene, in human hepatocellular carcinomas, HEPATOLOGY, 30(3), 1999, pp. 677-681
Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells
Authors: Wang, YP Ripperger, J Fey, GH Samols, D Kordula, T Wetzler, M Van Etten, RA Baumann, H
Citation: Yp. Wang et al., Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells, HEPATOLOGY, 30(3), 1999, pp. 682-697
Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration
Authors: Heller, J Sogni, P Tazi, KA Chagneau, C Poirel, O Moreau, R Lebrec, D
Citation: J. Heller et al., Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration, HEPATOLOGY, 30(3), 1999, pp. 698-704
Consistent infiltration of thymus-derived T cells into the parenchymal space of the liver in normal mice
Authors: Yamamoto, S Sato, Y Shimizu, T Halder, RC Oya, H Bannai, M Suzuki, K Ishikawa, H Hatakeyama, K Abo, T
Citation: S. Yamamoto et al., Consistent infiltration of thymus-derived T cells into the parenchymal space of the liver in normal mice, HEPATOLOGY, 30(3), 1999, pp. 705-713
Redox manipulation using the thiol-oxidizing agent diethyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model
Authors: Jones, JJ Fan, J Nathens, AB Kapus, A Shekhman, M Marshall, JC Parodo, J Rotstein, OD
Citation: Jj. Jones et al., Redox manipulation using the thiol-oxidizing agent diethyl maleate prevents hepatocellular necrosis and apoptosis in a rodent endotoxemia model, HEPATOLOGY, 30(3), 1999, pp. 714-724
The unique acyl chain specificity of biliary phosphatidylcholines in mice is independent of their biosynthetic origin in the liver
Authors: Agellon, LB Walkey, CJ Vance, DE Kuipers, F Verkade, HJ
Citation: Lb. Agellon et al., The unique acyl chain specificity of biliary phosphatidylcholines in mice is independent of their biosynthetic origin in the liver, HEPATOLOGY, 30(3), 1999, pp. 725-729
Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes
Authors: Pozzetti, L Piazza, F Cantelli-Forti, G Roda, A
Citation: L. Pozzetti et al., Bile acid structure and selective modulation of murine hepatic cytochrome P450-linked enzymes, HEPATOLOGY, 30(3), 1999, pp. 730-739
Deficient assembly and function of gap junctions in Trf1, a trafficking mutant of the human liver-derived cell line HuH-7
Authors: Stockert, RJ Spray, DC Gao, Y Suadicani, SO Ripley, CR Novikoff, PM Wolkoff, AW Hertzberg, EL
Citation: Rj. Stockert et al., Deficient assembly and function of gap junctions in Trf1, a trafficking mutant of the human liver-derived cell line HuH-7, HEPATOLOGY, 30(3), 1999, pp. 740-747
Targeting of aminopeptidase N to bile canaliculi correlates with secretoryactivities of the developing canalicular domain
Authors: Lian, WN Tsai, JW Yu, PM Wu, TW Yang, SC Chau, YP Lin, CH
Citation: Wn. Lian et al., Targeting of aminopeptidase N to bile canaliculi correlates with secretoryactivities of the developing canalicular domain, HEPATOLOGY, 30(3), 1999, pp. 748-760
Persistent activation of nuclear factor-kappa B in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of I kappa B family proteins
Authors: Elsharkawy, AM Wright, MC Hay, RT Arthur, MJP Hughes, T Bahr, MJ Degitz, K Mann, DA
Citation: Am. Elsharkawy et al., Persistent activation of nuclear factor-kappa B in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of I kappa B family proteins, HEPATOLOGY, 30(3), 1999, pp. 761-769
Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
Authors: Chien, RN Liaw, YF Atkins, M
Citation: Rn. Chien et al., Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B, HEPATOLOGY, 30(3), 1999, pp. 770-774
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation
Authors: Hezode, C Duvoux, C Germanidis, G Roudot-Thoraval, F Vincens, AL Gaulard, P Cherqui, D Pawlotsky, JM Dhumeaux, D
Citation: C. Hezode et al., Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation, HEPATOLOGY, 30(3), 1999, pp. 775-778
Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus
Authors: Ogata, N Cote, PJ Zanetti, AR Miller, RH Shapiro, M Gerin, J Purcell, RH
Citation: N. Ogata et al., Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus, HEPATOLOGY, 30(3), 1999, pp. 779-786
Racial differences in responses to therapy with interferon in chronic hepatitis C
Authors: Reddy, KR Hoofnagle, JH Tong, MJ Lee, WM Pockros, P Heathcote, EJ Albert, D Joh, T
Citation: Kr. Reddy et al., Racial differences in responses to therapy with interferon in chronic hepatitis C, HEPATOLOGY, 30(3), 1999, pp. 787-793
Current practice patterns of primary care physicians in the management of patients with hepatitis C
Authors: Shehab, TM Sonnad, SS Jeffries, M Gunaratnum, N Lok, ASF
Citation: Tm. Shehab et al., Current practice patterns of primary care physicians in the management of patients with hepatitis C, HEPATOLOGY, 30(3), 1999, pp. 794-800
Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data
Authors: Camma, C Giunta, M Chemello, L Alberti, A Toyoda, H Trepo, C Marcellin, P Zahm, F Schalm, S Craxi, A
Citation: C. Camma et al., Chronic hepatitis C: Interferon retreatment of relapsers. A meta-analysis of individual patient data, HEPATOLOGY, 30(3), 1999, pp. 801-807
Optimal treatment of biliary atresia - "Halfway" there!
Authors: Rudolph, JA Balistreri, WF
Citation: Ja. Rudolph et Wf. Balistreri, Optimal treatment of biliary atresia - "Halfway" there!, HEPATOLOGY, 30(3), 1999, pp. 808-810
Gene therapy for hepatic fibrosis - Bringing treatment into the new millennium
Authors: Rockey, DC
Citation: Dc. Rockey, Gene therapy for hepatic fibrosis - Bringing treatment into the new millennium, HEPATOLOGY, 30(3), 1999, pp. 816-818
The most frequent HFE allele linked to porphyria cutanea tarda in mediterraneans is His63Asp
Authors: de Salamanca, RE Morales, P Castro, MJ Rojo, R Gonzalez, M Arnaiz-Villena, A
Citation: Re. De Salamanca et al., The most frequent HFE allele linked to porphyria cutanea tarda in mediterraneans is His63Asp, HEPATOLOGY, 30(3), 1999, pp. 819-820
Surgery in patients with liver disease
Authors: Craxi, A Mariani, G
Citation: A. Craxi et G. Mariani, Surgery in patients with liver disease, HEPATOLOGY, 30(3), 1999, pp. 820-820
Risultati: << | 901-925 | 926-950 | 951-975 | 976-1000 | >>